Recent clinical trial results reinforce the potential of Affron, the saffron extract developed by Pharmactive Biotech Products, to support individuals with mild depressive symptoms. According to the company, the 12-week randomized, double-blind, placebo-controlled study is the most extensive to date for the ingredient and adds significant weight to the body of evidence supporting its role in mental wellness.
